课题基金 / 基金详情

'COVAIR': Is SARS-CoV-2 airborne and does it interact with particle pollutants?

'COVAIR': Is SARS-CoV-2 airborne and does it interact with particle pollutants?
“COVAIR”:SARS-CoV-2 是否通过空气传播?它是否与颗粒污染物相互作用?
批准号:
EP/V052462/1
负责人:
Kian Fan Chung
金额:
$65.74万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --

项目摘要

项目成果

Kian Fan Chung的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aerosol dispersion and environmental spread of SARS-CoV2 virus apart from direct inhalation oflarge droplets from a cough or exhaled breath of an infected person remains a high possibility.SARS-CoV2 virus has been collected from the air of hospitals with COVID-19 patients and thepresence of the virus on particulate matter has been reported in Northern Italy. We wish todevelop diagnostic tools and predictive sensing to detect SARS-CoV2 in crowded urbanenvironments in order to address whether the airborne amounts are high enough to cause arespiratory infection and whether pollution particles can carry live virus that is directly inhaled intothe lungs. We will determine whether SARS-CoV2 can be detected as active virus in the air ofhospitals with COVID-19 patients, and if so, use a similar technique to measure the virus incrowded spaces such as in underground train platforms, central station concourse, shopping mallsand busy roadside. We will use and validate different methods of collecting particles fromexperience obtained from our EPSRC-funded INHALE project. Particles will be collected onto filters,and virus and virus-particulate interactions determined by RT-PCR (RNA-based), culturing on VeroE6 cells and airway epithelial cells, and using state-of-the -art electron microscopy. We will modelthis mode of transmission into the lungs by studying airflows and pollutant levels, and as ameasure of this infection in the population. This method can be potentially considered as asurveillance assay of crowded public areas for SARS-CoV2 with ~ 2,000 new infections currentlyreported daily.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
The miR-196a SNP Rs11614913 but not the miR-499 rs37464444 SNP is a Risk Factor for Non-small Cell Lung Cancer in an Iranian Population
miR-196a SNP Rs11614913 但不是 miR-499 rs37464444 SNP 是伊朗人群非小细胞肺癌的危险因素
DOI: --
发表时间: 2022
期刊: Tanaffos
影响因子: --
作者: [Dezfuli N.K.]
通讯作者: Dezfuli N.K.
DOI: 10.1136/bmjresp-2022-001574
发表时间: 2023-05
期刊: BMJ open respiratory research
影响因子: 4.1
作者: []
通讯作者:
DOI: 10.3389/fnut.2022.975937
发表时间: 2022
期刊: FRONTIERS IN NUTRITION
影响因子: 5
作者: [Hashemian, Seyed MohammadReza, Mortaz, Esmaeil, Shafigh, Navid, Ziaie, Shadi, Jamaati, Hamidreza, Hasheminik, Morteza, Jamalinik, Mehdi, Erfani, Raziyeh, Khoundabi, Batoul, Dezfuli, Neda K., Varahram, Mohammad, Ahmadi, Shahrzad, Fahimi, Mahdi, Adcock, Ian M.]
通讯作者: Adcock, Ian M.
DOI: 10.1038/s41598-021-99579-0
发表时间: 2021-10-15
期刊: Scientific reports
影响因子: 4.6
作者: [Amani S, Shahrooz R, Hobbenaghi R, Mohammadi R, Baradar Khoshfetrat A, Karimi A, Bakhtiari Z, Adcock IM, Mortaz E]
通讯作者: Mortaz E
6
    MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
    • 批准号:
      MR/T010371/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $246.96万
    • 财政年份:
      2020
    • 负责人:
      Kian Fan Chung
    • 依托单位:
    Risk Assessment for Manufactured Nanoparticles Used in Consumer Products (RAMNUC)
    • 批准号:
      NE/H012893/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $146.88万
    • 财政年份:
      2011
    • 负责人:
      Kian Fan Chung
    • 依托单位:
    p38 MAPK activation as the basis for corticosteroid insensitivity in severe asthma
    • 批准号:
      G0700900/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $64.42万
    • 财政年份:
      2008
    • 负责人:
      Kian Fan Chung
    • 依托单位:
    国内基金
    海外基金
    SUMO化介导泛素化修饰类型调控N蛋白水平及SARS-CoV-2复制的机制研究
    • 批准号:
      JCZRQN202500077
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    SARS-CoV-2 VLP调控肿瘤微环境影响三阴性乳腺癌发生发展的机制 研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
    • 依托单位:
    靶向SARS-CoV-2 S1蛋白中药多糖活性化合物的筛选及构效关系研究